Clinical Trials Search Results

Results 21-30 of 344 for your search
Show Search Criteria
Nivolumab in Treating Patients with Metastatic or Recurrent Uterine Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 7 locations
Durvalumab with or without Tremelimumab in Treating Patients with Recurrent or Persistent Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 7 locations